welcomes you to the new, improved website!The efficacy of induction therapy for clinical T2 esophageal cancer was evaluated using the National Cancer Database. Pretreatment staging was accurate in only 27% of pts. 42% of pts were upstaged and 32% were downstaged. Induction therapy had no survival benefit.
You are here:
Induction Therapy Does Not Improve Survival for Clinical Stage T2N0 Esophageal Cancer
Submitted by: Mark Ferguson
Source: Journal of Thoracic Oncology
Keywords:
Author(s): Speicher, Paul J.; Ganapathi, Asvin M.; Englum, Brian R.; Hartwig, Matthew G.; Onaitis, Mark W.; D’Amico, Thomas A.; Berry, Mark F.
